Filing Details
- Accession Number:
- 0001209191-20-010554
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-19 16:38:51
- Reporting Period:
- 2020-02-17
- Accepted Time:
- 2020-02-19 16:38:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-17 | 1,248 | $241.50 | 18,440 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-18 | 240 | $241.95 | 18,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 640 | $242.80 | 17,560 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 202 | $243.85 | 17,358 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 280 | $245.00 | 17,078 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 202 | $245.74 | 16,876 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $241.95 (range $241.43 to $242.40).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $242.80 (range $242.45 to $243.32).
- Open market sales reported on this line occurred at a weighted average price of $243.85 (range $243.52 to $244.29).
- Open market sales reported on this line occurred at a weighted average price of $245.00 (range $244.52 to $245.43.)
- Open market sales reported on this line occurred at a weighted average price of $245.74 (range $245.55 to $245.86.)
Billionaire Hedge Funds
